Estimation of screening sensitivity and sojourn time from an organized screening program.

Area of Science:

• Oncology
• Public Health
• Medical Imaging

Background:

• Mammography screening aims to reduce breast cancer mortality but its net benefit is debated.
• Evaluating new screening techniques requires rapid assessment methods beyond long-term mortality studies.

Purpose of the Study:

• To develop a model for rapidly estimating screening effectiveness.
• To analyze the preclinical disease state duration and false negative rates in mammography screening.

Main Methods:

• Proposed a modeling procedure to estimate preclinical disease duration, false negative rate, and incidence.
• Applied the model to data from the Ontario Breast Screening Program.

Main Results:

• The mean preclinical duration for breast cancer appears to exceed 2 years.
• Screening every two years offers only marginal gains compared to screening every three years.
• Encouraging first-time screening attendance is identified as a key objective for screening programs.

Conclusions:

• The developed model provides a method for rapid evaluation of breast cancer screening interventions.
• Current screening intervals may not significantly optimize outcomes, highlighting the importance of initial participation.